pharmaphorum Podcast

CinCor Pharma: A small pharma’s journey to acquisition

In this episode of the pharmaphorum podcast, host Jonah Comstock welcomes Marc de Garidel, CEO of CinCor Pharma, which was just recently sold to AstraZeneca for more than $1 billion USD. Marc tells Jonah all about CinCor and its unique approach to hypertension, how the AstraZeneca deal came about, and what happens next.

AI trends in 2023

No matter what industry you’re in, artificial intelligence is a major topic around the water cooler. But while AI in popular culture may be at a peak of hype, AI in pharma is strending toward a moment of maturity, reliability, and scalability.
In today’s pharmaphorum podcast, brought to you by Syneos Health, Leigh Householder, EVP and MD technology and data solutions at Syneos Health and Noolie Gregory, VP decentralised clinical trial operations at Syneos Health, join host Jonah Comstock to talk about the Syneos Health 2023 Health Trends Report, particularly the opening section on AI: Finally Fit for Purpose.

Accelerating digital healthcare, with VITA

At the beginning of February, pharmaphorum web editor Nicole Raleigh travelled to Rome to cover the inaugural VITA Accelerator demo day. After the event, VITA’s senior programme manager Anastasiya Markvarde and managing director Paolo Borella took time to discuss the ethos behind the accelerator and the future of digital health start-ups in Italy and beyond.

Investing in healthcare’s future, with Paul Tunnah and Elia Stupka

Angelini Ventures is a recently launched investment fund seeking companies that are transformational in healthcare. pharmaphorum founder and Healthware Chief Content Officer Paul Tunnah, talks with co-Managing Director Elia Stupka about the new €300 million fund, how it started, how it’s going, and what health innovation looks like from the investor’s perspective.
This podcast was produced in partnership with Angelini Ventures and was originally published on Matthew Holt’s Healthcare Blog Podcast.

Solving problems in pathology data, with Nathan Buchbinder

 This time around on the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Nathan Buchbinder, cofounder and chief product officer at Proscia about pathology data, why it has taken so long to digitise it, and what the possibilities are when this data is freed from its historical siloes. 

How Moderna kept diversity in mind amid vaccine development

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna. 

Key themes from JP Morgan, with Paul Tunnah

pharmaphorum Editor-in-Chief Jonah Comstock and pharmaphorum Founder Paul Tunnah headed to San Francisco this week for the JP Morgan conference, the annual elbow-rubbing opportunity for biotech bigwigs. This is the first time the show has been back in person since COVID, and, despite some less than ideal weather, attendees were excited to resume in person collaboration.

Cancer control in a time of crisis

During The Economist’s 8th Annual World Cancer Series congress in Brussels last month, web editor Nicole Raleigh sat down to discuss the event and its themes with Greg Rossi, senior vice president, head of oncology Europe and Canada at AstraZeneca .

The scattered seeds of the beginnings of change

Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and what specifically had attracted Verheul to attend.

A few of the 2022’s biggest pharma trends

As we close out the year, the pharmaphorum editorial team sits down together for a roundtable discussion of some of the biggest trends they’ve tracked this year in the world of pharma.